FDA Takes Action Against Compounded Menopause Hormone Therapy Drugs (Medical News Today)
The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency.

FDA Approved Only 19 New Medications In 2007, Analyst Reports (Medical News Today)
FDA in 2007 approved 19 new medications, a decrease from 22 in 2006 and the lowest number since 1983, when the agency approved 14 new treatments, according to Ira Loss of Washington Analysis, Bloomberg/Arizona Daily Star reports. According to Loss, FDA in 2007 approved 17 "new molecular entities" and two biotechnology medications.